Related Experiment Video

Updated: May 28, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Novel mechanistic and clinical implications concerning the safety of statin discontinuation

Magdalena Jasińska-Stroschein1, Jacek Owczarek, Irena Wejman

  • 1Department of Biopharmacy, Medical University of Łódź, Muszyńskiego 1, PL 90-151 Łódź, Poland. magdalena.jasinska@umed.lodz.pl

Pharmacological Reports : PR
|October 18, 2011
PubMed

Insights

Statin discontinuation in cardiac patients may lead to adverse outcomes due to non-cholesterol effects. This review explores the detrimental impact of statin withdrawal on endothelial function and inflammation.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Statins are widely recognized for their benefits in cardiovascular disease prevention.
  • However, statin discontinuation is common in cardiac patients, potentially leading to adverse events.
  • These risks may extend beyond cholesterol-lowering effects, involving pleiotropic activities.

Purpose of the Study:

  • To review the mechanistic basis for adverse outcomes following statin withdrawal.
  • To explore the non-cholesterol-dependent, pleiotropic effects of statins.

Main Methods:

  • Literature review focusing on mechanistic studies of statin withdrawal.
  • Analysis of research on pleiotropic statin activities.

Main Results:

  • Statin withdrawal can negatively impact endothelial function.
  • Discontinuation may exacerbate inflammation and alter platelet activity.
  • Effects on AT1 signaling are also implicated in adverse outcomes.

Conclusions:

  • Statin withdrawal may have detrimental effects beyond lipid management.
  • Understanding these pleiotropic effects is crucial for assessing statin safety.
  • Further research is needed on clinical implications of statin discontinuation.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...